Jeong Seuk Kang
Chief Executive Officer presso March Therapeutics, Inc.
Profilo
Jeong Seuk Kang is the founder of DXLab, Inc. He is currently the CEO, Treasurer, Secretary & Director at March Therapeutics, Inc.
Posizioni attive di Jeong Seuk Kang
Società | Posizione | Inizio |
---|---|---|
March Therapeutics, Inc.
March Therapeutics, Inc. Medical/Nursing ServicesHealth Services Mitolab, Inc. provides healthcare services. The company is headquartered in Allston, MA. | Chief Executive Officer | - |
DXLab, Inc. (Massachusetts)
DXLab, Inc. (Massachusetts) Medical SpecialtiesHealth Technology DXLab, Inc. is an American Massachusetts-based company founded by Ho-Jun Suk, Jeong Seuk Kang, and Fahim Farzadfard, with Ho-Jun Suk serving as the CEO since incorporation. The company specializes in providing rapid and accurate point-of-care diagnostic testing for disease detection, particularly for COVID-19. The company's compact POC COVID-19 testing system allows for convenient testing of multiple samples at once, with accessible sample collection and a simple workflow. The system provides up to 8 accurate results in less than 30 minutes, making it a valuable tool for disease detection in areas without high-tech labs. The team at DXLab consists of engineers, physicists, biologists, and chemists working towards providing affordable disease detection where it is needed most. | Founder | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
March Therapeutics, Inc.
March Therapeutics, Inc. Medical/Nursing ServicesHealth Services Mitolab, Inc. provides healthcare services. The company is headquartered in Allston, MA. | Health Services |
DXLab, Inc. (Massachusetts)
DXLab, Inc. (Massachusetts) Medical SpecialtiesHealth Technology DXLab, Inc. is an American Massachusetts-based company founded by Ho-Jun Suk, Jeong Seuk Kang, and Fahim Farzadfard, with Ho-Jun Suk serving as the CEO since incorporation. The company specializes in providing rapid and accurate point-of-care diagnostic testing for disease detection, particularly for COVID-19. The company's compact POC COVID-19 testing system allows for convenient testing of multiple samples at once, with accessible sample collection and a simple workflow. The system provides up to 8 accurate results in less than 30 minutes, making it a valuable tool for disease detection in areas without high-tech labs. The team at DXLab consists of engineers, physicists, biologists, and chemists working towards providing affordable disease detection where it is needed most. | Health Technology |
- Borsa valori
- Insiders
- Jeong Seuk Kang